Orencia vs. Folate: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Orencia and Folate. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 334,055 people who take Orencia and Folate, and is updated regularly.
What is Orencia?
Orencia has active ingredients of abatacept. It is often used in rheumatoid arthritis. eHealthMe is studying from 135,415 Orencia users. Check the latest studies of Orencia.
What is Folate?
Folate has active ingredients of folic acid. It is often used in rheumatoid arthritis. eHealthMe is studying from 6,546 Folate users. Check the latest studies of Folate.
334,055 people who take Orencia and Folate are studied.

Drugs being compared in this study:
- Orencia (abatacept)
- Folate (folic acid)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Orencia:
- not at all: 8.57 %
- somewhat: 24.49 %
- moderate: 31.84 %
- high: 24.49 %
- very high: 10.61 %
Folate:
- not at all: 4.83 %
- somewhat: 21.51 %
- moderate: 36.2 %
- high: 27.0 %
- very high: 10.46 %
Want to compare Orencia with Folate?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Orencia:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Folate:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on abatacept and folic acid (the active ingredients of Orencia and Folate, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Atrovent cause Arterial Disorder? - 5 seconds ago
- Hypertension Aggravated and Tinnitus - 8 seconds ago
- Could Rabeprazole cause Lung Neoplasm? - 12 seconds ago
- Could Atropine cause Plantar Fasciitis? - 12 seconds ago
- Could Evenity cause Memory Loss? - 13 seconds ago
- Could Rimantadine Hydrochloride cause Lymphadenopathy Mediastinal? - 20 seconds ago
- Could Nicoderm Cq cause Neck Pain? - 23 seconds ago
- Hyperlipidaemia and Lip Erosion - 29 seconds ago
- Drug interactions of Maxzide and Zoloft - 35 seconds ago
- Could Ribapak cause Drug Administration Error? - 36 seconds ago